GWSG
TNDM icon

GPS Wealth Strategies Group’s Tandem Diabetes Care TNDM Stock Holding History

GPS Wealth Strategies Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-319
Closed -$12.9K – 1440
2024
Q2 		$12.9K Hold
319
– – ﹤0.01% 860
2024
Q1 		$11.3K Sell
319
-50
-14% -$1.34K ﹤0.01% 829
2023
Q4 		$10.9K Sell
369
-131
-26% -$2.72K ﹤0.01% 821
2023
Q3 		$10.4K Sell
500
-158
-24% -$4.34K ﹤0.01% 831
2023
Q2 		$16.1K Hold
658
– – ﹤0.01% 738
2023
Q1 		$26.7K Buy
+658
New +$27.2K 0.01% 632
2022
Q4 		– Sell
-855
Closed -$41K – 990
2022
Q3 		$41K Sell
855
-190
-18% -$10.4K 0.01% 470
2022
Q2 		$62K Sell
1,045
-99
-9% -$8.13K 0.02% 406
2022
Q1 		$133K Buy
1,144
+46
+4% +$5.37K 0.03% 264
2021
Q4 		$165K Hold
1,098
– – 0.04% 231
2021
Q3 		$131K Sell
1,098
-9
-0.8% -$992 0.03% 245
2021
Q2 		$108K Buy
1,107
+451
+69% +$40.2K 0.03% 290
2021
Q1 		$57K Buy
+656
New +$61K 0.02% 365

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GPS Wealth Strategies Group's TNDM Position: Q3 2024 in Review

GPS Wealth Strategies Group sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 319 shares — an estimated $12.9K sold.

GPS Wealth Strategies Group first reported a position in TNDM in Q1 2021 and held it in 13 quarters. The position peaked at $165K in Q4 2021. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • GPS Wealth Strategies Group reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 319 Tandem Diabetes Care shares in Q3 2024, an estimated $12.9K.
  • GPS Wealth Strategies Group first reported a position in Tandem Diabetes Care in Q1 2021 and held it in 13 quarters.
  • GPS Wealth Strategies Group's Tandem Diabetes Care position peaked at $165K in Q4 2021.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q3 2024, filed 29 Oct 2024.